Ronald Daniels - Director, Bridgebio Pharma, Inc
As of December 30, 2021
Ronald Daniels Net Worth
- Net worth is estimated to be at least $241.04K
- Owns at least 10,402 units of Bridgebio Pharma, Inc stock
- Sold an estimated value of $150.34K in the last year at Bridgebio Pharma, Inc
Ronald Daniels Trading
- Largest purchase of shares was 22,147 units , worth over $298.68K on December 30, 2021
- Largest sale of shares was 11,745 units , worth over $150.34K on December 30, 2021
- In total has made about 3 transactions over a year
- Usually trades in February, June and December, with the busiest year in 2021
RONALD DANIELS
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
Ronald Daniels Mailing Address
- Mailing address is C/o Moore Corporation Limited One Canterbury Green Stamford CT 06901 CT
Bridgebio Pharma, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Neil Kumar, Ph.D. | 2020 | $550,000 | $825,000 | $2,368,511 | $6,299,998 | $11,400 | $10,054,909 |
| Neil Kumar, Ph.D. | 2019 | $502,765 | $360,000 | $13,863,445 | $11,573,049 | $34,804 | $26,334,063 |
| Neil Kumar, Ph.D. | 2018 | $450,000 | - | - | - | - | $450,000 |
| Brian Stephenson, Ph.D., CFA | 2020 | $550,000 | $712,500 | $789,494 | $2,099,996 | $11,943 | $4,163,933 |
| Brian Stephenson, Ph.D., CFA | 2019 | $420,000 | $189,000 | $132,600 | $3,430,781 | $26,586 | $4,198,967 |
| Brian Stephenson, Ph.D., CFA | 2018 | $74,375 | $330,240 | $1,942,500 | - | - | $2,347,115 |
| Michael Henderson, M.D. | 2020 | $515,000 | $300,000 | $7,072,500 | $91,899 | $11,843 | $7,991,241 |
| Cameron Turtle, Ph.D.* | 2020 | $400,000 | $210,000 | $3,940,081 | - | $11,400 | $4,561,482 |
| Charles Homcy, M.D. | 2020 | $500,000 | $100,000 | - | $1,199,992 | $55,812 | $1,855,805 |
| Charles Homcy, M.D. | 2019 | $513,808 | - | $2,111,579 | $3,128,716 | $221,737 | $5,975,842 |
| Brian Stolz | 2020 | $511,362 | $25,000 | $736,854 | $1,992,182 | $1,975,453 | $5,240,851 |
| Brian Stolz | 2019 | $146,780 | $93,750 | $6,860,780 | $1,045,003 | - | $8,146,313 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1743881/000119312521145491/d131567ddef14a.htm
Bridgebio Pharma, Inc Insider Trading
- The most recent transaction was 12,000 units bought on March 17, 2022 by Andrea Ellis worth over $100.68K
- In the last 3 years, insiders at Bridgebio Pharma, Inc sold an estimated value of $351.74M and bought an estimated value of $213.34M
- The most active traders are Neil Kumar, CEO and President, Brian C Stephenson, See Remarks, and Thomas Michael Henderson, Chief Business Officer
- Insider trading is most common in June, with the busiest year in 2020
BridgeBio Pharma, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||